This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LeadingBiotech: Cancer Advance
March 5, 2020
Koch Institute for Integrative Cancer Research at MITCambridge, MA

March 5, 2020
Koch Institute for Integrative Cancer Research at MIT,
Cambridge, MA



We're leading influence through renowned leadership made of diverse voices. This dynamic group brings a wealth of knowledge and industry insights to the forefront. By working harmoniously together, the team's direction will facilitate better collaboration and richer discussion among industry leaders.

Wendy Nelson Ph.D. — CEO

“My vision for this business is to be one of the premier networking and content-rich conference series in the life sciences ecosystem. I’ll leverage my experience and passion of running my own Boston Biotech Forum to help move this company forward with heightened engagement and worthwhile discussion.”

Nelson joined the company in October 2018 as CEO. In her role, Nelson is re-energizing the business by leading the execution of several substantial developments. She has over 20 years of operational, business development, and R&D experience within the biotech and biopharma fields. Nelson is also President & Founder of the Boston Biotech Forum dinner event series. She has significantly contributed to the life sciences community by building that series into one of the most successful networking events in Boston biotech. Nelson received her Sc.B. and M.S. in Engineering and her Ph.D. in Medical Sciences from Brown University.

Robert Buderi — Chairman

"In my role, I'm excited to bring forward the most relevant topics and pressing trends in our industry. It's my goal to give senior executives a one-of-a-kind opportunity for sharing ideas and contributing to meaningful discussion with their peers.”

Buderi has served in this role since May 2018. He advises on overall strategy and helps pinpoint important issues affecting businesses in biotech and biopharma. As the Founder & Editor-in-Chief of Xconomy and past Editor of MIT’s Technology Review, Buderi has decades of experience in the field. Buderi is also a published author and was a regular guest of CNBC’s Strategy Session. He’s spoken about innovation to many organizations, including the Business Council, Amazon, eBay, Google, IBM, and Microsoft. Buderi received his A.B. in Psychology, Physical Education at University of California, Davis and his M.A. in Journalism at University of Arizona.

AMBASSADOR COMMITTEE (established in 2018)

Under Bob Buderi’s chairmanship, this select group of Ambassadors will work collectively to advise on topics and trends that give the business an edge up on staying current and looking ahead. The committee of experts will strengthen the discussion with fresh outlooks and in-depth insight.